Showing results (1-10 of 21) with videos related to
Sort By:
Pageof 3
Expert Review of Vaccines|August 9, 2003
Vaccination with heat shock protein-peptide complexes: from basic science to clinical applicationsAxel Hoos, Daniel L LeveyImmunology Today|August 1, 1996
Alterations in T cells of cancer-bearers: whence specificity?D L Levey, P K SrivastavaThe Journal of Experimental Medicine|October 1, 1995
T cells from late tumor-bearing mice express normal levels of p56lck, p59fyn, ZAP-70, and CD3 zeta despite suppressed cytolytic activityD L Levey, P K SrivastavaThe Journal of Experimental Zoology|March 1, 1978
Effects of alpha-amanitin on RNA synthesis by mouse embryos in cultureI L Levey, R L BrinsterJournal of HIV Therapy|January 3, 2006
The potential of heat shock protein-peptide complexes as a therapeutic HIV vaccineDaniel L Levey, Christian Brander, Pramod K SrivastavaDevelopments in Biologicals|December 18, 2004
Autologous heat shock protein-peptide complexes for vaccination against cancer: from bench to bedsideA Hoos, D L Levey, J J LewisProceedings of the National Academy of Sciences of the United States of America|April 12, 1994
Cellular requirements for tumor-specific immunity elicited by heat shock proteins: tumor rejection antigen gp96 primes CD8+ T cells in vivoH Udono, D L Levey, P K SrivastavaUrologic Oncology|September 12, 2006
Autologous renal cell cancer vaccines using heat shock protein-peptide complexesMaryam Aalamian, Ephraim Fuchs, Renu Gupta, et al.The Journal of Biological Chemistry|March 25, 1979
Protein degradation in the mouse blastocystR L Brinster, S Brunner, X Joseph, et al.Cancer Immunity|May 16, 2003
Identification of a tumor-associated contact-dependent activity which reversibly downregulates cytolytic function of CD8+ T cellsD L Levey, H Udono, M Heike, et al.Pageof 3